As part of the France 2030 Investment Plan launched by the French government, PEPR PROPSY, with the support of Fondation FondaMental, was selected to strengthen clinical and pre-clinical research in precision psychiatry.
A central component of PROPSY is the development of French Minds, a large-scale longitudinal and deeply phenotyped cohort supported by a multimodal database.
PEPR PROPSY, represented by INSERM, along with Fondation FondaMental and the NIHR MH-TRC, entered into a Memorandum of Understanding to formalises a consortium, with the shared intent to advance precision psychiatry, through :
- reciprocal access to datasets and biosample cohorts,
- the harmonisation of blood-sampling criteria and multi-omics workflows,
- joint projects on genomic and immuno-metabolic biomarkers,
- exchanges of researchers and students,
- coordinated efforts to secure external funding with public- and private-sector partners.
This Consortium took place in London, on April 13-14, 2026.
A call for applications has been opened for doctoral and postdoctoral students to encourage their participation in the Consortium. They will :
- Showcase their research to international experts
- Engage in discussions on mental health biomarkers
- Network with leading UK and French scientists
The Consortium program is here.